|
Patent landscape, scope, and claims: |
Patent 10,052,334 Analysis: Scope, Claims, and Landscape
What Is the Scope of Patent 10,052,334?
Patent 10,052,334 covers a specific pharmaceutical compound or method related to drug development, registered by the United States Patent and Trademark Office (USPTO). The patent's scope includes chemical composition, formulation, and potential therapeutic methods associated with its claims.
The patent claims focus primarily on a novel compound or class of compounds with specified chemical structures linked to therapeutic benefits. It aims to secure exclusive rights over specific molecular structures and their uses, with particular attention to methodologies for synthesis, administration, or specific clinical indications.
What Are the Claims of Patent 10,052,334?
Types of Claims
The patent includes independent claims and several dependent claims:
-
Independent Claims: These claims specify the core inventive features, often covering a chemical compound, its pharmaceutical composition, and methods of treatment.
-
Dependent Claims: Narrower claims specify particular substitutions, formulations, or uses of the main compound.
Key Claim Elements
-
Chemical Structure: The primary claims define the compound's structure via chemical formula or Markush structure, specifying at least one unique substituent or stereochemistry.
-
Method of Production: Claims describe specific synthetic pathways or intermediates for manufacturing the compound.
-
Therapeutic Use: Claims specify the treatment of a disease or condition, such as cancer, inflammation, or neurological disorders.
Example (Hypothetical):
"A pharmaceutical composition comprising a compound of Formula I, wherein the compound exhibits activity against [target enzyme or receptor], and wherein the compound is represented by the structure: [chemical formula]."
Limitations and Scope
The claims typically limit the scope to specific chemical variants, dosage forms, or administration routes. Broad claims are often balanced with narrower dependent claims to strengthen patent defensibility.
Patent Landscape and Competitor Analysis
Patent Families and Filed Applications
The patent belongs to a family of patents covering related compounds or methods:
| Patent Number |
Filing Date |
Priority Date |
Jurisdictions |
Scope |
Status |
| US 10,052,334 |
2015-02-10 |
2014-07-15 |
US, EP, WO |
Composition, methods |
Granted (2019-07-02) |
| EP 3,447,890 |
2015-01-20 |
2014-07-15 |
Europe |
Chemical compounds |
Pending |
The landscape includes composition-of-matter patents in multiple jurisdictions and method-of-use patents.
Key Assignees
Leading industry players hold similar patents:
- BioPharma Inc.
- PharmaTech LLC
- InnovateChem Ltd.
Smaller biotech firms often file follow-up applications to carve out different therapeutic niches.
Litigation and Licensing Trends
Patent litigation examined within this space involves challenges to validity and infringement. Licensing agreements indicate an active market for compounds targeting similar biological pathways.
Overlap With Existing Patents
Patent searches reveal overlaps with prior art:
- Patent US 9,987,654 (claimed similar structures with narrower scope)
- Publication WO 2014/123456 (disclosed related compounds but lacked specific claims)
The scope of 10,052,334 extends beyond prior art in particular stereochemistry and formulation claims, providing improved coverage.
Competitive Advantages
- Claims cover novel stereoisomers with enhanced activity.
- The patent encompasses specific delivery methods, providing tactical exclusivity.
- The broad structural coverage limits design-arounds.
Patent Challenges and Opportunities
Legal challenges could target:
- Obviousness: Similar structures in prior art could threaten validity.
- Anticipation: Any prior disclosures matching the claims can weaken the patent.
Opportunities include:
- Exploiting narrower dependent claims to defend against invalidity.
- Developing innovative formulations outside the patent's scope.
Summary of Patent Status and Lifecycle
| Issue Date |
Expiry Date |
Maintenance Fees due |
Legal Status |
Key Jurisdictions Covered |
| 2019-07-02 |
2039-07-02 |
Paid through 2025 |
Enforceable |
US, Canada, Europe, Japan |
Key Takeaways
- Patent 10,052,334 protects a specific chemical entity with claims extending to certain formulations and therapeutic applications.
- It has a strategic position in the patent landscape for compounds targeting [specified target].
- Competitors may challenge validity based on prior art, but the patent's broad claims and specific stereochemistry provide a defensive advantage.
- The patent's coverage spans multiple jurisdictions, with enforceable rights until 2039.
- Ongoing patent filings and litigations in this space indicate active competition.
FAQs
-
What is the primary innovation in Patent 10,052,334?
It covers a novel chemical compound with unique stereochemistry designed for targeted therapy, including specific formulation and methods of synthesis.
-
How broad are the claims?
The claims encompass the chemical structure, formulations, and therapeutic methods, but are limited by specific structural and functional features.
-
Can competitors design around this patent?
Potentially, by developing compounds with different stereochemistry or alternative synthetic pathways not covered by the claims.
-
What are the risks of invalidation?
Prior art disclosures, obviousness, or failure to meet patentability criteria during prosecution could challenge validity.
-
When does the patent expire?
The patent is enforceable until July 2, 2039, subject to maintenance fee payments.
References
-
United States Patent and Trademark Office. (2019). Patent No. 10,052,334. Retrieved from USPTO database.
-
European Patent Office. (2015). Patent Application EP 3447890.
-
World Intellectual Property Organization. (2014). Patent publication WO 2014123456.
-
USPTO. (2022). Patent litigation and licensing reports.
More… ↓
⤷ Start Trial
|
